These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37881068)
1. METTL14 Regulates the m6A Modification of TRAF6 to Suppress Mitochondrial Dysfunction and Ferroptosis in Dopaminergic Neurons via the cGAS-STING Pathway. Shao L; Hu F; Xu R; Nie H; Zhang H; Zhang P Curr Mol Med; 2024; 24(12):1518-1528. PubMed ID: 37881068 [TBL] [Abstract][Full Text] [Related]
2. METTL14-Mediated m6A Modification of Gu X; Song Y; Liu X; Cheng Z; Min J; Zhang Y Front Biosci (Landmark Ed); 2024 Aug; 29(8):298. PubMed ID: 39206905 [TBL] [Abstract][Full Text] [Related]
3. METTL14 promotes chondrocyte ferroptosis in osteoarthritis via m6A modification of GPX4. Liu D; Ren L; Liu J Int J Rheum Dis; 2024 Aug; 27(8):e15297. PubMed ID: 39175261 [TBL] [Abstract][Full Text] [Related]
4. METTL3-Mediated N 6 -Methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis. Tsai YC; Hsieh TH; Liao YR; Tsai MT; Lin TP; Lee DY; Park J; Kim D; Susztak K; Yang SF; Lin CC; Li SY J Am Soc Nephrol; 2024 Oct; 35(10):1312-1329. PubMed ID: 39352860 [TBL] [Abstract][Full Text] [Related]
5. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer. Li L; Zeng J; He S; Yang Y; Wang C Cancer Biol Ther; 2024 Dec; 25(1):2349429. PubMed ID: 38738555 [TBL] [Abstract][Full Text] [Related]
6. METTL14-mediated N6-methyladenosine modification induces the ferroptosis of hypoxia/reoxygenation-induced cardiomyocytes. Zhao C; Li J J Cardiothorac Surg; 2024 Apr; 19(1):265. PubMed ID: 38664788 [TBL] [Abstract][Full Text] [Related]
7. Neuropeptide substance P attenuates colitis by suppressing inflammation and ferroptosis via the cGAS-STING signaling pathway. Lan J; Deng Z; Wang Q; Li D; Fan K; Chang J; Ma Y Int J Biol Sci; 2024; 20(7):2507-2531. PubMed ID: 38725846 [TBL] [Abstract][Full Text] [Related]
8. m6A methyltransferase METTL3 contributes to sympathetic hyperactivity post-MI via promoting TRAF6-dependent mitochondrial ROS production. Yang P; Wang Y; Ge W; Jing Y; Hu H; Yin J; Xue M; Wang Y; Li X; Li X; Shi Y; Tan J; Li Y; Yan S Free Radic Biol Med; 2023 Nov; 209(Pt 2):342-354. PubMed ID: 37898386 [TBL] [Abstract][Full Text] [Related]
9. Soot nanoparticles promote ferroptosis in dopaminergic neurons via alteration of m6A RNA methylation in Parkinson's disease. Feng J; Zhang P; Chen K; Huang P; Liang X; Dong J; Zhu B; Fu Z; Deng T; Zhu L; Chen C; Zhang Y J Hazard Mater; 2024 Jul; 473():134691. PubMed ID: 38788584 [TBL] [Abstract][Full Text] [Related]
10. Acteoside alleviates lipid peroxidation by enhancing Nrf2-mediated mitophagy to inhibit ferroptosis for neuroprotection in Parkinson's disease. Han Z; Wang B; Wen YQ; Li YN; Feng CX; Ding XS; Shen Y; Yang Q; Gao L Free Radic Biol Med; 2024 Oct; 223():493-505. PubMed ID: 39048340 [TBL] [Abstract][Full Text] [Related]
11. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion. Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395 [TBL] [Abstract][Full Text] [Related]
12. m6A RNA methylation regulates mitochondrial function. Kahl M; Xu Z; Arumugam S; Edens B; Fischietti M; Zhu AC; Platanias LC; He C; Zhuang X; Ma YC Hum Mol Genet; 2024 May; 33(11):969-980. PubMed ID: 38483349 [TBL] [Abstract][Full Text] [Related]
13. TLR9 regulates the autophagy-lysosome pathway to promote dendritic cell maturation and activation by activating the TRAF6-cGAS-STING pathway. Liu Y; Wei FZ; Zhan YW; Wang R; Mo BY; Lin SD Kaohsiung J Med Sci; 2023 Dec; 39(12):1200-1212. PubMed ID: 37850718 [TBL] [Abstract][Full Text] [Related]
14. Ubiquitination of cGAS by TRAF6 regulates anti-DNA viral innate immune responses. Chen X; Chen Y Biochem Biophys Res Commun; 2019 Jun; 514(3):659-664. PubMed ID: 31078259 [TBL] [Abstract][Full Text] [Related]
15. Ganoderic acid A mitigates dopaminergic neuron ferroptosis via inhibiting NCOA4-mediated ferritinophagy in Parkinson's disease mice. Li QM; Wu SZ; Zha XQ; Zang DD; Zhang FY; Luo JP J Ethnopharmacol; 2024 Oct; 332():118363. PubMed ID: 38763373 [TBL] [Abstract][Full Text] [Related]
16. METTL14 is decreased and regulates m He H; Zhang Q; Liao J; Lei J; Luo M; Huang J; Chen M; Shen Y; Wang J; Xu P; Xiao Y J Neurochem; 2023 Aug; 166(3):609-622. PubMed ID: 37309980 [TBL] [Abstract][Full Text] [Related]
17. BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity. Bao Y; Pan Z; Zhao L; Qiu J; Cheng J; Liu L; Qian D J Transl Med; 2024 May; 22(1):519. PubMed ID: 38816831 [TBL] [Abstract][Full Text] [Related]
18. Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and ferroptosis in Parkinson's disease. Fu X; Qu L; Xu H; Xie J Exp Neurol; 2024 May; 375():114724. PubMed ID: 38365133 [TBL] [Abstract][Full Text] [Related]
19. WTAP-mediated N6-methyladenosine modification promotes the inflammation, mitochondrial damage and ferroptosis of kidney tubular epithelial cells in acute kidney injury by regulating LMNB1 expression and activating NF-κB and JAK2/STAT3 pathways. Huang F; Wang Y; Lv X; Huang C J Bioenerg Biomembr; 2024 Jun; 56(3):285-296. PubMed ID: 38517565 [TBL] [Abstract][Full Text] [Related]
20. METTL14 plays an oncogenic role in NSCLC by modulating ferroptosis and the m6A modification of GPX4. Lou Y; Huang K; Xu B; Chen X Arch Physiol Biochem; 2024 Dec; 130(6):962-973. PubMed ID: 38993012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]